A new synthetic route to obtain the carboxylate analog of mannose 6-phosphate (M6-P) is presented. The effects of the M6-P, the carboxylate and two other analogs (the phosphonate and the α,β ethylenic carboxylate) on the proliferation of human keratinocytes and dermal fibroblasts as well as on the proliferation of a murine fibroblast cell line, 3T3-J2 are tested. We observed that M6-P is a potent inhibitor of proliferation of both fibroblasts and keratinocytes. Among its analogs, the phosphonate showed a similar effect on human dermal fibroblasts but not on keratinocytes.
{"title":"Synthesis and biological activity of M6-P and M6-P analogs on fibroblast and keratinocyte proliferation","authors":"Caroline Clavel , Véronique Barragan-Montero , Xavier Garric , Jean-Pierre Molès , Jean-Louis Montero","doi":"10.1016/j.farmac.2005.06.006","DOIUrl":"10.1016/j.farmac.2005.06.006","url":null,"abstract":"<div><p>A new synthetic route to obtain the carboxylate<span> analog of mannose 6-phosphate (M6-P) is presented. The effects of the M6-P, the carboxylate and two other analogs (the phosphonate and the α,β ethylenic carboxylate) on the proliferation of human keratinocytes and dermal fibroblasts as well as on the proliferation of a murine fibroblast cell line, 3T3-J2 are tested. We observed that M6-P is a potent inhibitor of proliferation of both fibroblasts and keratinocytes. Among its analogs, the phosphonate showed a similar effect on human dermal fibroblasts but not on keratinocytes.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 721-725"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25194602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-09-01DOI: 10.1016/j.farmac.2005.04.015
Cinzia Bersani, Manuela Berna, Gianfranco Pasut, Francesco Maria Veronese
Metronidazole (MTZ), a drug used for the treatment of protozoal infections caused by protozoa and anaerobic microorganisms, was conjugated to linear or branched poly(ethylene glycol) of 5,000, 10,000 and 20,000 Da. An ester linkage between polymer and drug was used in the coupling to yield a polymeric prodrug. The modification allowed overcoming the known MTZ solubility problem leading us to obtain a bioconjugate more suitable for parental administration. The conjugates of various molecular weight polymers have been tested in vitro toward chemical degradation and digestive enzymes. It was found that molecular weight and shape of PEG is critical for the prodrugs stability. Good resistance in the stomach acidic media was found and a slow release of the drug in the large intestinal fluid may take place. In vivo studies carried out following i.v. or s.c. administration to mice revealed improved pharmacokinetics properties upon conjugation.
{"title":"PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties","authors":"Cinzia Bersani, Manuela Berna, Gianfranco Pasut, Francesco Maria Veronese","doi":"10.1016/j.farmac.2005.04.015","DOIUrl":"10.1016/j.farmac.2005.04.015","url":null,"abstract":"<div><p><span><span>Metronidazole (MTZ), a drug used for the treatment of </span>protozoal infections caused by protozoa and </span>anaerobic microorganisms<span>, was conjugated to linear or branched poly(ethylene glycol) of 5,000, 10,000 and 20,000 Da. An ester linkage between polymer and drug was used in the coupling to yield a polymeric prodrug. The modification allowed overcoming the known MTZ solubility problem leading us to obtain a bioconjugate more suitable for parental administration. The conjugates of various molecular weight polymers have been tested in vitro toward chemical degradation and digestive enzymes. It was found that molecular weight and shape of PEG is critical for the prodrugs stability. Good resistance in the stomach acidic media was found and a slow release of the drug in the large intestinal fluid may take place. In vivo studies carried out following i.v. or s.c. administration to mice revealed improved pharmacokinetics properties upon conjugation.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 783-788"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.04.015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25208292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, acute myocardial infarction, congestive heart failure, renal failure, pulmonary hypertension, and atherosclerosis. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ETA) and endothelin B (ETB), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an “hit compound” with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (29–52) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ETA and ETB receptors.
{"title":"A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands","authors":"Valeria Pittalà , Maria Modica , Giuseppe Romeo , Luisa Materia , Loredana Salerno , Mariangela Siracusa , Alfredo Cagnotto , Ilario Mereghetti , Filippo Russo","doi":"10.1016/j.farmac.2005.06.005","DOIUrl":"10.1016/j.farmac.2005.06.005","url":null,"abstract":"<div><p><span><span><span>Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, </span>acute myocardial infarction<span><span>, congestive heart failure, renal failure, </span>pulmonary hypertension, and </span></span>atherosclerosis<span>. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ET</span></span><sub>A</sub>) and endothelin B (ET<sub>B</sub><span>), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an “hit compound” with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (</span><em>29–52</em><span>) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ET</span><sub>A</sub> and ET<sub>B</sub> receptors.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 711-720"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25208461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-09-01DOI: 10.1016/j.farmac.2005.06.012
A. Zarghi , S.M. Foroutan , A. Shafaati , A. Khoddam
A rapid, simple and sensitive high-performance liquid chromatography (HPLC) method has been developed for quantification of amlodipine in plasma. The assay enables the measurement of amlodipine for therapeutic drug monitoring with a minimum detectable limit of 0.2 ng ml−1. The method involves simple, one-step extraction procedure and analytical recovery was about 97%. The separation was performed on an analytical 125 × 4.6 mm i.d. Nucleosil C8 column. The wavelength was set at 239 nm. The mobile phase was a mixture of 0.01 M sodium dihydrogen phosphate buffer and acetonitrile (63:37, v/v) adjusted to pH 3.5 at a flow rate of 1.5 ml min–1. The calibration curve was linear over the concentration range 0.5–16 ng ml−1. The coefficients of variation for inter-day and intra-day assay were found to be less than 10%.
建立了一种快速、简便、灵敏的高效液相色谱法测定血浆中氨氯地平的含量。该检测方法能够测量用于治疗药物监测的氨氯地平,最低检测限为0.2 ng ml−1。方法简单,一步提取,分析回收率约为97%。采用125 × 4.6 mm id的核sil C8色谱柱进行分离。波长为239 nm。流动相为0.01 M磷酸二氢钠缓冲液与调节pH为3.5的乙腈(63:37,v/v)的混合物,流速为1.5 ml min-1。在0.5 ~ 16 ng ml−1的浓度范围内,校准曲线呈线性。日间和日间测定的变异系数均小于10%。
{"title":"Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studies","authors":"A. Zarghi , S.M. Foroutan , A. Shafaati , A. Khoddam","doi":"10.1016/j.farmac.2005.06.012","DOIUrl":"10.1016/j.farmac.2005.06.012","url":null,"abstract":"<div><p><span><span>A rapid, simple and sensitive high-performance liquid chromatography (HPLC) method has been developed for quantification of amlodipine in plasma. The assay enables the measurement of amlodipine for </span>therapeutic drug monitoring with a minimum detectable limit of 0.2 ng ml</span><sup>−1</sup>. The method involves simple, one-step extraction procedure and analytical recovery was about 97%. The separation was performed on an analytical 125<!--> <!-->×<!--> <!-->4.6 mm i.d. Nucleosil C<sub>8</sub><span> column. The wavelength was set at 239 nm. The mobile phase was a mixture of 0.01 M sodium dihydrogen phosphate buffer and acetonitrile (63:37, v/v) adjusted to pH 3.5 at a flow rate of 1.5 ml min</span><sup>–1</sup>. The calibration curve was linear over the concentration range 0.5–16 ng ml<sup>−1</sup>. The coefficients of variation for inter-day and intra-day assay were found to be less than 10%.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 9","pages":"Pages 789-792"},"PeriodicalIF":0.0,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.06.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24916920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-08-01DOI: 10.1016/j.farmac.2005.05.009
Annalisa Tait, Amedeo Luppi, Rossella Avallone, Mario Baraldi
A series of N-1,3 disubstituted 2,1,3-benzothiadiazine derivatives (BTDs) were synthesized and evaluated for their inhibitory activity versus enzymatic isoform PDE4 extracted from U937 cell line. Some of the tested compounds showed a high PDE4 inhibitory activity at 100 μM and the IC50 value of the most interesting terms were evaluated. The structure–activity relationships of these compounds showed that the 3,5-di-tert-butyl-4-hydroxybenzyl moiety at N-1 position is important to obtain activity at micromolar level as previously reported. For the same compounds the antioxidant activity were evaluated highlighting 14 as the most significative one. The introduction of other bulky substituents in N-1 position is detrimental.
{"title":"2,1,3-Benzothiadiazine derivatives: synthesis and screening versus PDE4 enzyme","authors":"Annalisa Tait, Amedeo Luppi, Rossella Avallone, Mario Baraldi","doi":"10.1016/j.farmac.2005.05.009","DOIUrl":"10.1016/j.farmac.2005.05.009","url":null,"abstract":"<div><p>A series of N-1,3 disubstituted 2,1,3-benzothiadiazine derivatives (BTDs) were synthesized and evaluated for their inhibitory activity versus enzymatic isoform PDE4 extracted from U937 cell line. Some of the tested compounds showed a high PDE4 inhibitory activity at 100 μM and the IC<sub>50</sub> value of the most interesting terms were evaluated. The structure–activity relationships of these compounds showed that the 3,5-di-<em>tert-</em><span>butyl-4-hydroxybenzyl moiety at N-1 position is important to obtain activity at micromolar level as previously reported. For the same compounds the antioxidant activity were evaluated highlighting </span><strong>14</strong> as the most significative one. The introduction of other bulky substituents in N-1 position is detrimental.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 653-663"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.05.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24852298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-08-01DOI: 10.1016/j.farmac.2005.01.007
Marco A. Ciufolini
This article reviews past and ongoing research in the author's laboratory directed toward the synthesis of natural products displaying an azaspirocyclic framework, or incorporating a medium-ring nitrogen heterocycle. New synthetic technologies were devised in order to address the synthetic problems posed by the target molecules. Thus, efforts in the area of azaspirocyclic substances have relied on an oxidative amidation of phenols promoted by iodobenzene diacetate, whereas access to medium-ring nitrogen heterocycles has been secured by means of a ring expansion sequence that relies on the fragmentation of an aziridine triggered by a homo-Brook transposition. Details of the development of these technologies are presented, together with applications to the total synthesis of FR-901483, TAN-1251C, cylindricines, and mitomycinoids.
{"title":"Synthetic studies on heterocyclic natural products","authors":"Marco A. Ciufolini","doi":"10.1016/j.farmac.2005.01.007","DOIUrl":"10.1016/j.farmac.2005.01.007","url":null,"abstract":"<div><p><span>This article reviews past and ongoing research in the author's laboratory directed toward the synthesis of natural products displaying an azaspirocyclic framework, or incorporating a medium-ring nitrogen heterocycle. New synthetic technologies were devised in order to address the synthetic problems posed by the target molecules. Thus, efforts in the area of azaspirocyclic substances have relied on an oxidative amidation of phenols promoted by iodobenzene </span>diacetate<span>, whereas access to medium-ring nitrogen heterocycles has been secured by means of a ring expansion sequence that relies on the fragmentation of an aziridine triggered by a homo-Brook transposition. Details of the development of these technologies are presented, together with applications to the total synthesis of FR-901483, TAN-1251C, cylindricines, and mitomycinoids.</span></p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 627-641"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.01.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25243330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-08-01DOI: 10.1016/j.farmac.2005.04.013
C. Vetuschi , A. Giannandrea , G. Carlucci , P. Mazzeo
The fourth-order derivative spectrum from the alcoholic sample is used. HCT can be determined by a specific peak–trough, of low intensity, at 330–340 nm. For IST evaluation, a peak–trough around 250–310 nm is available, common to both products, whose amplitude increases linearly only for low concentration values, while it decreases at higher values. The most difficult aspect of the analysis lies in how to find the optimal concentration range, so that both signals can be evaluated simultaneously. The best results were achieved by using a linear regression for HCT and a regression plane for IST.
{"title":"Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry","authors":"C. Vetuschi , A. Giannandrea , G. Carlucci , P. Mazzeo","doi":"10.1016/j.farmac.2005.04.013","DOIUrl":"10.1016/j.farmac.2005.04.013","url":null,"abstract":"<div><p><span>The fourth-order derivative spectrum from the alcoholic sample is used. HCT can be determined by a specific peak–trough, of low intensity, at 330–340 nm. For </span>IST evaluation, a peak–trough around 250–310 nm is available, common to both products, whose amplitude increases linearly only for low concentration values, while it decreases at higher values. The most difficult aspect of the analysis lies in how to find the optimal concentration range, so that both signals can be evaluated simultaneously. The best results were achieved by using a linear regression for HCT and a regression plane for IST.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 665-670"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.04.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24852297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2005-08-01DOI: 10.1016/j.farmac.2005.05.004
André L. Santos, Regina M. Takeuchi, Marcela P. Mariotti, Marcelo F. De Oliveira, Maria V.B. Zanoni, Nelson R. Stradiotto
In this work, electrochemical oxidation of albendazole (ABZ) was carried out using a glassy carbon-rotating disk electrode. Development of electroanalytical methodology for ABZ quantification in pharmaceutical formulations was also proposed by using linear sweep voltammetric technique. Electrochemical oxidation is observed for ABZ at E1/2 = 0.99 V vs. Ag/AgClsat, when an anodic wave is observed. Kinetic parameters obtained for ABZ oxidation exhibited a standard heterogeneous rate constant for the electrodic process equal to (1.51 ± 0.07) × 10–5 cm s–1, with a αna value equal to 0.76. Limiting current dependence against ABZ concentration exhibited linearity on 5.0 × 10–5 to 1.0 × 10–2 mol l–1 range, being obtained a detection limit of 2.4 × 10–5 mol l–1. Proposed methodology was applied to ABZ quantification in pharmaceutical formulations.
{"title":"Study of electrochemical oxidation and determination of albendazole using a glassy carbon-rotating disk electrode","authors":"André L. Santos, Regina M. Takeuchi, Marcela P. Mariotti, Marcelo F. De Oliveira, Maria V.B. Zanoni, Nelson R. Stradiotto","doi":"10.1016/j.farmac.2005.05.004","DOIUrl":"10.1016/j.farmac.2005.05.004","url":null,"abstract":"<div><p><span>In this work, electrochemical oxidation of albendazole (ABZ) was carried out using a glassy carbon-rotating disk electrode. Development of electroanalytical methodology for ABZ quantification in pharmaceutical formulations was also proposed by using linear sweep voltammetric technique. Electrochemical oxidation is observed for ABZ at </span><em>E</em><sub>1/2</sub> <!-->=<!--> <!-->0.99 V vs. Ag/AgCl<sub>sat</sub>, when an anodic wave is observed. Kinetic parameters obtained for ABZ oxidation exhibited a standard heterogeneous rate constant for the electrodic process equal to (1.51<!--> <!-->±<!--> <!-->0.07)<!--> <!-->×<!--> <!-->10<sup>–5</sup> cm s<sup>–1</sup>, with a <em>αn</em><sub>a</sub> value equal to 0.76. Limiting current dependence against ABZ concentration exhibited linearity on 5.0<!--> <!-->×<!--> <!-->10<sup>–5</sup> to 1.0<!--> <!-->×<!--> <!-->10<sup>–2</sup> mol l<sup>–1</sup> range, being obtained a detection limit of 2.4<!--> <!-->×<!--> <!-->10<sup>–5</sup> mol l<sup>–1</sup>. Proposed methodology was applied to ABZ quantification in pharmaceutical formulations.</p></div>","PeriodicalId":77128,"journal":{"name":"Farmaco (Societa chimica italiana : 1989)","volume":"60 8","pages":"Pages 671-674"},"PeriodicalIF":0.0,"publicationDate":"2005-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.farmac.2005.05.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25140500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}